Senem Ertugrul Mut

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Multiple Sclerosis

Top Venues

Clinical neuropharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Senem Ertugrul Mut, Ferda Selcuk, Sıla Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology (2024)
Senem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology 47 (4) (2024)
Senem Ertugrul Mut, Ferda Selcuk, Sıla Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology (2024)
Senem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology 47 (4) (2024)